Clinical Study

Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research)

Table 7

Subgroup analyses according to waistline—mean ± SE ().

NGT ()HINS ()IGT ()T2DM ()
Non-central-obesity ()Central-obesity ()Non-central-obesity ()Central-obesity ()Non-central-obesity ()Central-obesity ()

Age 44.40 ± 11.7442.82 ± 10.0348.20 ± 5.5544.90 ± 8.74
Weight62.20 ± 6.7569.68 ± 6.5465.65 ± 5.4067.85 ± 7.42
BMI22.41 ± 1.5424.94 ± 1.8624.79 ± 2.5123.98 ± 1.68
Waistline 76.75 ± 7.7281.36 ± 6.7182.00 ± 6.0484.60 ± 5.15
WHR0.90 ± 0.110.89 ± 0.090.90 ± 0.060.93 ± 0.06
TG1.24 ± 0.732.45 ± 1.641.67 ± 0.991.42 ± 0.41
HDL1.62 ± 0.351.42 ± 0.241.35 ± 0.391.13 ± 0.25
FINS5.29 ± 4.619.34 ± 6.117.84 ± 5.417.46 ± 8.06
value7.26 ± 1.70
Matsuda index13.16 ± 7.245.75 ± 2.354.12 ± 1.218.92 ± 3.858.26 ± 4.29

Notes: comparison among HINS, IGT, and T2DM groups, , compared with non-central-obesity subgroups; in central-obesity subgroups, comparison among different glucose tolerance groups, compared with HINS-central-obesity group and , compared with IGT-central-obesity group.